跳至主要内容
临床试验/JPRN-UMIN000038905
JPRN-UMIN000038905招募中未知

Autologous peripheral blood stem cell transplantation for elderly patients (65-74 years old) with multiple myeloma. - PBSCT for elderly MM

Tokyo-Kita Medical Center0 个研究点目标入组 20 人开始时间: 2020年1月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 74years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Classified to Frail by IMWG-frailty index or R-MCI, or HCT-CI score above 3. 2) Hypersensitivity to the drugs used in this study. 3) Pregnant or lactating patients 4) Any significant medical condition, laboratory abnormality, or psychiatric illness that would prevent the subject from participating in the study

研究者

相似试验

已完成
不适用
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)
JPRN-UMIN000026084agoya University Graduate School of Medicine10
已完成
不适用
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1
JPRN-UMIN000012546ishiwaki Municipal Hospital18
已完成
2 期
Autologous peripheral blood stem cell transplantation using MEAM regimen with HAART for refractory and relapsed HIV associated lymphoma: multicentered phase2 clinical trialRefractory and relapsed HIV associated lymphoma
JPRN-UMIN000003159Research fund of Ministry Health, Labour and Welfare for a counter measure against AIDS, Okada group and Tanabe group18
尚未招募
不适用
Autologous Peripheral Blood Stem Cell Treatment for Myocardial Regeneration in Acute Myocardial InfarctioDiseases of the circulatory system
KCT0006114Seoul National University Hospital105
已完成
不适用
autologous hematopoietic stem cell transplantation followed by reduced intensity allogeneic stem cell transplantation for relatively young patients with multiple myelomamultiple myeloma
JPRN-UMIN000002533The university of Tokyo Hospital,department of hematology and oncology20